| Gene Symbol |
Definition |
Felxi PID |
Halo PID |
Nluc-N PID |
Nluc-C PID |
| FZR1 |
fizzy/cell division cycle 20 related 1, transcript variant 2 |
FXC00776
|
FHC00776
|
FNC00776N
|
FNC00776C
|
| TP53BP1 |
tumor protein p53 binding protein 1, transcript variant 2 |
FXC00998
|
FHC00998
|
FNC00998N
|
FNC00998C
|
| SMC1A |
structural maintenance of chromosomes 1A, transcript variant 1 |
FXC01055
|
FHC01055
|
FNC01055N
|
FNC01055C
|
| STAG1 |
stromal antigen 1 |
FXC01192
|
FHC01192
|
FNC01192N
|
FNC01192C
|
| BUB1B |
BUB1 mitotic checkpoint serine/threonine kinase B |
FXC01224
|
FHC01224
|
FNC01224N
|
FNC01224C
|
| RB1 |
retinoblastoma 1 |
FXC01227
|
FHC01227
|
FNC01227N
|
FNC01227C
|
| WEE1 |
WEE1 G2 checkpoint kinase, transcript variant 1 |
FXC01243
|
FHC01243
|
FNC01243N
|
FNC01243C
|
| CDC27 |
cell division cycle 27, transcript variant 2 |
FXC01271
|
FHC01271
|
FNC01271N
|
FNC01271C
|
| RBL1 |
retinoblastoma-like 1, transcript variant 1 |
FXC01328
|
FHC01328
|
FNC01328N
|
FNC01328C
|
| ABL1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase, transcript variant b |
FXC01406
|
FHC01406
|
FNC01406N
|
FNC01406C
|
| YWHAG |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma |
FXC01431
|
FHC01431
|
FNC01431N
|
FNC01431C
|
| GSK3B |
glycogen synthase kinase 3 beta, transcript variant 2 |
FXC01477
|
FHC01477
|
FNC01477N
|
FNC01477C
|
| YWHAH |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta |
FXC01503
|
FHC01503
|
FNC01503N
|
FNC01503C
|
| CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1), transcript variant 1 |
FXC01536
|
FHC01536
|
FNC01536N
|
FNC01536C
|
| CCND1 |
cyclin D1 |
FXC01554
|
FHC01554
|
FNC01554N
|
FNC01554C
|
| SMAD4 |
SMAD family member 4 |
FXC01560
|
FHC01560
|
FNC01560N
|
FNC01560C
|
| CCND3 |
cyclin D3, transcript variant 2 |
FXC01582
|
FHC01582
|
FNC01582N
|
FNC01582C
|
| CCND2 |
cyclin D2 |
FXC01585
|
FHC01585
|
FNC01585N
|
FNC01585C
|
| CDK7 |
cyclin-dependent kinase 7 |
FXC01723
|
FHC01723
|
FNC01723N
|
FNC01723C
|
| SKP2 |
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase, transcript variant 1 |
FXC01758
|
FHC01758
|
FNC01758N
|
FNC01758C
|
| EP300 |
E1A binding protein p300 |
FXC01787
|
FHC01787
|
FNC01787N
|
FNC01787C
|
| SKP1 |
S-phase kinase-associated protein 1, transcript variant 2 |
FXC01803
|
FHC01803
|
FNC01803N
|
FNC01803C
|
| ANAPC1 |
anaphase promoting complex subunit 1 |
FXC01858
|
FHC01858
|
FNC01858N
|
FNC01858C
|
| MCM2 |
minichromosome maintenance complex component 2, transcript variant 1 |
FXC01953
|
FHC01953
|
FNC01953N
|
FNC01953C
|
| RAD21 |
RAD21 cohesin complex component |
FXC01957
|
FHC01957
|
FNC01957N
|
FNC01957C
|
| MCM5 |
minichromosome maintenance complex component 5 |
FXC02155
|
FHC02155
|
FNC02155N
|
FNC02155C
|
| PTTG1 |
pituitary tumor-transforming 1, transcript variant 2 |
FXC02516
|
FHC02516
|
FNC02516N
|
FNC02516C
|
| HDAC1 |
histone deacetylase 1 |
FXC02563
|
FHC02563
|
FNC02563N
|
FNC02563C
|
| E2F2 |
E2F transcription factor 2 |
FXC02567
|
FHC02567
|
FNC02567N
|
FNC02567C
|
| YWHAQ |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta |
FXC02639
|
FHC02639
|
FNC02639N
|
FNC02639C
|
| SMAD3 |
SMAD family member 3, transcript variant 1 |
FXC02648
|
FHC02648
|
FNC02648N
|
FNC02648C
|
| CDK2 |
cyclin-dependent kinase 2, transcript variant 1 |
FXC02738
|
FHC02738
|
FNC02738N
|
FNC02738C
|
| CDKN1B |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
FXC02790
|
FHC02790
|
FNC02790N
|
FNC02790C
|
| GADD45A |
growth arrest and DNA-damage-inducible, alpha, transcript variant 1 |
FXC02792
|
FHC02792
|
FNC02792N
|
FNC02792C
|
| REXO2 |
RNA exonuclease 2 |
FXC02878
|
FHC02878
|
FNC02878N
|
FNC02878C
|
| CCNA1 |
cyclin A1, transcript variant 1 |
FXC02900
|
FHC02900
|
FNC02900N
|
FNC02900C
|
| CDKN2A |
cyclin-dependent kinase inhibitor 2A |
FXC03080
|
FHC03080
|
FNC03080N
|
FNC03080C
|
| BUB3 |
BUB3 mitotic checkpoint protein |
FXC03145
|
FHC03145
|
FNC03145N
|
FNC03145C
|
| SFN |
stratifin |
FXC03323
|
FHC03323
|
FNC03323N
|
FNC03323C
|
| SMAD2 |
SMAD family member 2, transcript variant 1 |
FXC03382
|
FHC03382
|
FNC03382N
|
FNC03382C
|
| CHEK1 |
checkpoint kinase 1, transcript variant 3 |
FXC03424
|
FHC03424
|
FNC03424N
|
FNC03424C
|
| ZBTB17 |
zinc finger and BTB domain containing 17, transcript variant 2 |
FXC03524
|
FHC03524
|
FNC03524N
|
FNC03524C
|
| MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
FXC03542
|
FHC03542
|
FNC03542N
|
FNC03542C
|
| ORC3 |
origin recognition complex, subunit 3, transcript variant 1 |
FXC03740
|
FHC03740
|
FNC03740N
|
FNC03740C
|
| ORC1 |
origin recognition complex, subunit 1, transcript variant 1 |
FXC03771
|
FHC03771
|
FNC03771N
|
FNC03771C
|
| ORC4 |
origin recognition complex, subunit 4, transcript variant 2 |
FXC03962
|
FHC03962
|
FNC03962N
|
FNC03962C
|
| MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
FXC03984
|
FHC03984
|
FNC03984N
|
FNC03984C
|
| CCNB2 |
cyclin B2 |
FXC04480
|
FHC04480
|
FNC04480N
|
FNC04480C
|
| CDC45 |
cell division cycle 45, transcript variant 2 |
FXC04508
|
FHC04508
|
FNC04508N
|
FNC04508C
|
| CDKN2D |
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4), transcript variant 1 |
FXC04524
|
FHC04524
|
FNC04524N
|
FNC04524C
|
| CHEK2 |
checkpoint kinase 2, transcript variant 3 |
FXC04554
|
FHC04554
|
FNC04554N
|
FNC04554C
|
| CUL1 |
cullin 1 |
FXC04681
|
FHC04681
|
FNC04681N
|
FNC04681C
|
| GADD45G |
growth arrest and DNA-damage-inducible, gamma |
FXC05255
|
FHC05255
|
FNC05255N
|
FNC05255C
|
| HDAC2 |
histone deacetylase 2 |
FXC05328
|
FHC05328
|
FNC05328N
|
FNC05328C
|
| MCM7 |
minichromosome maintenance complex component 7, transcript variant 2 |
FXC05950
|
FHC05950
|
FNC05950N
|
FNC05950C
|
| CDKN2C |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4), transcript variant 1 |
FXC06074
|
FHC06074
|
FNC06074N
|
FNC06074C
|
| PCNA |
proliferating cell nuclear antigen, transcript variant 1 |
FXC06294
|
FHC06294
|
FNC06294N
|
FNC06294C
|
| ORC6 |
origin recognition complex, subunit 6, transcript variant 1 |
FXC06441
|
FHC06441
|
FNC06441N
|
FNC06441C
|
| RBX1 |
ring-box 1, E3 ubiquitin protein ligase |
FXC06613
|
FHC06613
|
FNC06613N
|
FNC06613C
|
| ANAPC10 |
anaphase promoting complex subunit 10, transcript variant 2 |
FXC07460
|
FHC07460
|
FNC07460N
|
FNC07460C
|
| YWHAZ |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta, transcript variant 1 |
FXC07727
|
FHC07727
|
FNC07727N
|
FNC07727C
|
| CDKN2B |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4), transcript variant 1 |
FXC07728
|
FHC07728
|
FNC07728N
|
FNC07728C
|
| TTK |
TTK protein kinase, transcript variant 1 |
FXC07900
|
FHC07900
|
FNC07900N
|
FNC07900C
|
| MCM3 |
minichromosome maintenance complex component 3 |
FXC08015
|
FHC08015
|
FNC08015N
|
FNC08015C
|
| CDK4 |
cyclin-dependent kinase 4 |
FXC08159
|
FHC08159
|
FNC08159N
|
FNC08159C
|
| BUB3 |
BUB3 mitotic checkpoint protein, transcript variant 1 |
FXC08223
|
FHC08223
|
FNC08223N
|
FNC08223C
|
| CCNH |
cyclin H, transcript variant 1 |
FXC08237
|
FHC08237
|
FNC08237N
|
FNC08237C
|
| TFDP1 |
transcription factor Dp-1, transcript variant 1 |
FXC08570
|
FHC08570
|
FNC08570N
|
FNC08570C
|
| ORC2 |
origin recognition complex, subunit 2, transcript variant 1 |
FXC08756
|
FHC08756
|
FNC08756N
|
FNC08756C
|
| PLK1 |
polo-like kinase 1 |
FXC08757
|
FHC08757
|
FNC08757N
|
FNC08757C
|
| MAD2L2 |
MAD2 mitotic arrest deficient-like 2 (yeast), transcript variant 2 |
FXC08775
|
FHC08775
|
FNC08775N
|
FNC08775C
|
| CDC23 |
cell division cycle 23 |
FXC08907
|
FHC08907
|
FNC08907N
|
FNC08907C
|
| CDC25A |
cell division cycle 25A, transcript variant 1 |
FXC08963
|
FHC08963
|
FNC08963N
|
FNC08963C
|
| E2F4 |
E2F transcription factor 4, p107/p130-binding |
FXC09474
|
FHC09474
|
FNC09474N
|
FNC09474C
|
| CCNE1 |
cyclin E1 |
FXC09571
|
FHC09571
|
FNC09571N
|
FNC09571C
|
| YWHAE |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon, transcript variant 1 |
FXC09696
|
FHC09696
|
FNC09696N
|
FNC09696C
|
| CDC20 |
cell division cycle 20 |
FXC09751
|
FHC09751
|
FNC09751N
|
FNC09751C
|
| CDC6 |
cell division cycle 6 |
FXC10183
|
FHC10183
|
FNC10183N
|
FNC10183C
|
| ANAPC2 |
anaphase promoting complex subunit 2 |
FXC10289
|
FHC10289
|
FNC10289N
|
FNC10289C
|
| TP53 |
tumor protein p53, transcript variant 1 |
FXC10374
|
FHC10374
|
FNC10374N
|
FNC10374C
|
| MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
FXC10454
|
FHC10454
|
FNC10454N
|
FNC10454C
|
| CDK6 |
cyclin-dependent kinase 6, transcript variant 1 |
FXC10565
|
FHC10565
|
FNC10565N
|
FNC10565C
|
| GADD45B |
growth arrest and DNA-damage-inducible, beta |
FXC10610
|
FHC10610
|
FNC10610N
|
FNC10610C
|
| MAD2L1 |
MAD2 mitotic arrest deficient-like 1 (yeast) |
FXC10633
|
FHC10633
|
FNC10633N
|
FNC10633C
|
| MDM2 |
MDM2 proto-oncogene, E3 ubiquitin protein ligase, transcript variant 1 |
FXC10775
|
FHC10775
|
FNC10775N
|
FNC10775C
|
| CCNE2 |
cyclin E2 |
FXC10829
|
FHC10829
|
FNC10829N
|
FNC10829C
|
| CDC16 |
cell division cycle 16, transcript variant 1 |
FXC10960
|
FHC10960
|
FNC10960N
|
FNC10960C
|
| TGFB2 |
transforming growth factor, beta 2, transcript variant 1 |
FXC10973
|
FHC10973
|
FNC10973N
|
FNC10973C
|
| E2F5 |
E2F transcription factor 5, p130-binding, transcript variant 1 |
FXC10985
|
FHC10985
|
FNC10985N
|
FNC10985C
|
| CDC7 |
cell division cycle 7, transcript variant 1 |
FXC10990
|
FHC10990
|
FNC10990N
|
FNC10990C
|
| ORC5 |
origin recognition complex, subunit 5, transcript variant 1 |
FXC11057
|
FHC11057
|
FNC11057N
|
FNC11057C
|
| ANAPC5 |
anaphase promoting complex subunit 5, transcript variant 1 |
FXC11084
|
FHC11084
|
FNC11084N
|
FNC11084C
|
| PMEPA1 |
prostate transmembrane protein, androgen induced 1, transcript variant 1 |
FXC11398
|
FHC11398
|
FNC11398N
|
FNC11398C
|
| TFDP2 |
transcription factor Dp-2 (E2F dimerization partner 2), transcript variant 2 |
FXC11405
|
FHC11405
|
FNC11405N
|
FNC11405C
|
| PKMYT1 |
protein kinase, membrane associated tyrosine/threonine 1, transcript variant 1 |
FXC11420
|
FHC11420
|
FNC11420N
|
FNC11420C
|
| BUB1 |
BUB1 mitotic checkpoint serine/threonine kinase, transcript variant 1 |
FXC11721
|
FHC11721
|
FNC11721N
|
FNC11721C
|
| CREBBP |
CREB binding protein, transcript variant 1 |
FXC11778
|
FHC11778
|
FNC11778N
|
FNC11778C
|
| YWHAB |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta, transcript variant 1 |
FXC11790
|
FHC11790
|
FNC11790N
|
FNC11790C
|
| SMC3 |
structural maintenance of chromosomes 3 |
FXC11813
|
FHC11813
|
FNC11813N
|
FNC11813C
|
| STAG2 |
stromal antigen 2, transcript variant 4 |
FXC11817
|
FHC11817
|
FNC11817N
|
FNC11817C
|
| ATR |
ATR serine/threonine kinase |
FXC11858
|
FHC11858
|
FNC11858N
|
FNC11858C
|
| CCNB1 |
cyclin B1 |
FXC11869
|
FHC11869
|
FNC11869N
|
FNC11869C
|
| E2F3 |
E2F transcription factor 3, transcript variant 1 |
FXC12471
|
FHC12471
|
FNC12471N
|
FNC12471C
|
| ANAPC7 |
anaphase promoting complex subunit 7, transcript variant 1 |
FXC12559
|
FHC12559
|
FNC12559N
|
FNC12559C
|
| MAD1L1 |
MAD1 mitotic arrest deficient-like 1 (yeast), transcript variant 1 |
FXC12616
|
FHC12616
|
FNC12616N
|
FNC12616C
|
| ANTXR1 |
anthrax toxin receptor 1, transcript variant 1 |
FXC21030
|
FHC21030
|
FNC21030N
|
FNC21030C
|
| MCM6 |
minichromosome maintenance complex component 6 |
FXC21186
|
FHC21186
|
FNC21186N
|
FNC21186C
|
| ANAPC13 |
anaphase promoting complex subunit 13, transcript variant 2 |
FXC21699
|
FHC21699
|
FNC21699N
|
FNC21699C
|
| CDC25C |
cell division cycle 25C, transcript variant 1 |
FXC22295
|
FHC22295
|
FNC22295N
|
FNC22295C
|
| SLC25A2 |
solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 2 |
FXC22328
|
FHC22328
|
FNC22328N
|
FNC22328C
|
| MCM4 |
minichromosome maintenance complex component 4, transcript variant 1 |
FXC23263
|
FHC23263
|
FNC23263N
|
FNC23263C
|
| ZNF367 |
zinc finger protein 367 |
FXC23565
|
FHC23565
|
FNC23565N
|
FNC23565C
|
| CDC14B |
cell division cycle 14B, transcript variant 2 |
FXC23567
|
FHC23567
|
FNC23567N
|
FNC23567C
|
| CDC26 |
cell division cycle 26 |
FXC23609
|
FHC23609
|
FNC23609N
|
FNC23609C
|
| CDK1 |
cyclin-dependent kinase 1, transcript variant 1 |
FXC23867
|
FHC23867
|
FNC23867N
|
FNC23867C
|
| CDKN1C |
cyclin-dependent kinase inhibitor 1C (p57, Kip2), transcript variant 1 |
FXC24118
|
FHC24118
|
FNC24118N
|
FNC24118C
|
| TGFB3 |
transforming growth factor, beta 3 |
FXC25244
|
FHC25244
|
FNC25244N
|
FNC25244C
|
| ANAPC11 |
anaphase promoting complex subunit 11, transcript variant 1 |
FXC26221
|
FHC26221
|
FNC26221N
|
FNC26221C
|
| E2F1 |
E2F transcription factor 1 |
FXC26966
|
FHC26966
|
FNC26966N
|
FNC26966C
|
| TGFB1 |
transforming growth factor, beta 1 |
FXC28628
|
FHC28628
|
FNC28628N
|
FNC28628C
|
| HDAC2 |
histone deacetylase 2, transcript variant 1 |
|
FHC31712
|
FNC31712N
|
FNC31712C
|
